The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. “Saliva testing will help with the global shortage of swabs for sampling and increase testing […]
Recent Posts
- Virginia’s New Dental Scaling Law: What It Means for Dental Hygienists, Dental Assistants, and Patient Safety
- Why Orthodontists Are No Longer America’s Highest-Paid Professionals
- MDS Students Must Maintain 80% Biometric Attendance, Says NDC
- Will Dental Robots Prepare Crowns in the Future? A Critical Review of the University of Basel Miniature Intraoral Robot
- From Blade to Book: The History of Medicine and Surgery from Ancient Egypt to Sushruta and Ibn Sina
Archives